FN1 and breast carcinoma: In a recent study by Kawamoto et al., the authors proposed TM contributes to limiting metastases by binding to ECM protein fibronectin, blocking adhesive integrins expressed by breast carcinoma cells from binding fibronectin and initiating tumor cell migration [82].